Gujrathi Sheilainsider trades
In SEC Form 4 filings, Gujrathi Sheila is listed as Chief Strategy Officer of Bolt Biotherapeutics, Inc. (BOLT). Gujrathi Sheila reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 27.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| BOLTBolt Biotherapeutics, Inc. | Chief Strategy Officer | 4 | Oct 27 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-27
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| BOLTBolt Biotherapeutics, Inc. | Oct 23 | Oct 27 | A | 72,766 | $0.00 | $0 | 72,766 | No | Form 4 |
| BOLTBolt Biotherapeutics, Inc. | Oct 23 | Oct 27 | A | 13,055 | $0.00 | $0 | 13,055 | No | Form 4 |
| BOLTBolt Biotherapeutics, Inc. | Oct 23 | Oct 27 | J · derivative | 2,763.83 | not reported | not reported | 2,763.83 | No | Form 4 |
| BOLTBolt Biotherapeutics, Inc. | Oct 23 | Oct 27 | J · derivative | 495.87 | not reported | not reported | 495.87 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.